Showing results (1-10 of 655) with videos related to
Sort By:
Pageof 66
Blut|January 1, 1985
The use of heat-treated Factor VIII-concentrates in von Willebrand's diseaseM Köhler, P Hellstern, E WenzelThrombosis and Haemostasis|August 30, 1983
Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrodeP Hellstern, K Schilz, G von Blohn, et al.Klinische Wochenschrift|August 1, 1986
[Bolus injection of anisoylated plasminogen-streptokinase activator complex (BRL 26921) as an alternative concept of systemic lysis in acute myocardial infarct]P Doenecke, H Schwerdt, P Hellstern, et al.Acta Haematologica|January 1, 1983
Arterial and venous thrombosis and normal response to streptokinase treatment in a young patient with severe Hageman factor deficiencyP Hellstern, M Köhler, K Schmengler, et al.Thrombosis and Haemostasis|December 27, 1982
Thrombin-induced platelet malondialdehyde (MDA) formation in normal subjects and in women taking oral contraceptivesP Hellstern, C Miyashita, M Köhler, et al.Thrombosis and Haemostasis|February 28, 1986
Comparative study of intranasal, subcutaneous and intravenous administration of desamino-D-arginine vasopressin (DDAVP)M Köhler, P Hellstern, C Miyashita, et al.Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1984
[Significance of disordered antithrombin III function in disseminated intravascular coagulation and deep venous thrombosis for anticoagulant therapy]G von Blohn, B Reiter, P Hellstern, et al.Behring Institute Mitteilungen|February 1, 1986
[Fibrinolytic treatment of deep vein thrombosis and lung embolism]P Scheffler, G von Blohn, P Hellstern, et al.Klinische Wochenschrift|June 1, 1984
The subcutaneous administration of the vasopressin analogue 1-desamino-8-D-arginine vasopressin in patients with von Willebrand's disease and hemophiliaM Köhler, P Hellstern, B Reiter, et al.Blut|July 1, 1984
In vitro characterization of commercial Factor VIII concentrates: long-term follow-upC Miyashita, P Hellstern, M Köhler, et al.Pageof 66